These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9035121)

  • 1. Boehringer Mannheim's new clot buster.
    Nat Biotechnol; 1997 Feb; 15(2):114. PubMed ID: 9035121
    [No Abstract]   [Full Text] [Related]  

  • 2. New clot busters threaten Genentech's tPA.
    Davidson S
    Nat Biotechnol; 1997 May; 15(5):405. PubMed ID: 9131608
    [No Abstract]   [Full Text] [Related]  

  • 3. On 'jumbo' and 'junkie' trials. A fumbled affair, a jungle, or the ultimate solution?
    Hugenholtz PG
    Eur Heart J; 1991 Feb; 12(2):101-2. PubMed ID: 1904349
    [No Abstract]   [Full Text] [Related]  

  • 4. Laboratory and clinical experience with recombinant plasminogen activator.
    Builder SE; Grossbard E
    Prog Clin Biol Res; 1986; 211():303-13. PubMed ID: 3083430
    [No Abstract]   [Full Text] [Related]  

  • 5. [Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study].
    Franzosi MG
    Ital Heart J Suppl; 2001 Sep; 2(9):1034-6. PubMed ID: 11675828
    [No Abstract]   [Full Text] [Related]  

  • 6. Genentech falls at the last fence in race to market heart drug.
    Anderson A
    Nature; 1987 Jun 11-17; 327(6122):450. PubMed ID: 3108670
    [No Abstract]   [Full Text] [Related]  

  • 7. Reteplase in acute myocardial infarction.
    Busti AJ; Marshall KS; Hooper JS
    JAMA; 2004 May; 291(20):2429-30; author reply 2430. PubMed ID: 15161887
    [No Abstract]   [Full Text] [Related]  

  • 8. Stenting versus thrombolysis in acute myocardial infarction trial (STAT).
    Indian Heart J; 2001; 53(3):375. PubMed ID: 11516047
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary angioplasty or t-PA for the management of acute myocardial infarction?
    Bailey G; Flynn CA
    J Fam Pract; 1999 Aug; 48(8):577-8. PubMed ID: 10496629
    [No Abstract]   [Full Text] [Related]  

  • 10. Tissue plasminogen activator after retinal artery occlusion.
    Marmor MF
    Ophthalmology; 1999 Dec; 106(12):2231-2. PubMed ID: 10599645
    [No Abstract]   [Full Text] [Related]  

  • 11. Reteplase.
    Dimens Crit Care Nurs; 1999; 18(6):23. PubMed ID: 10640049
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatocyte growth factor plasma levels after myocardial infarction are not affected by recombinant tissue-type plasminogen-activator therapy.
    Molnar C; Buratti T; Wiedermann CJ; Tilg H
    Eur Cytokine Netw; 2000 Mar; 11(1):87-90. PubMed ID: 10705304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human tissue plasminogen activator without heparin is effective in the treatment of hepatic veno-occlusive disease.
    Gherlinzoni F; Vianelli N; Valdrè L; Catani L; Tani M; Tura S
    Haematologica; 1999 Feb; 84(2):191-2. PubMed ID: 10091426
    [No Abstract]   [Full Text] [Related]  

  • 14. [Staphylokinase--a specific plasminogen activator].
    Rozpończyk E; Szemraj J; Malinowski M; Rozpończyk J
    Postepy Biochem; 2006; 52(1):80-6. PubMed ID: 16869305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alfimeprase to succeed Genentech's alteplase?
    Vastag B
    Nat Biotechnol; 2006 Aug; 24(8):875-6. PubMed ID: 16900112
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children.
    Jacobs BR; Haygood M; Hingl J
    J Pediatr; 2001 Oct; 139(4):593-6. PubMed ID: 11598611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal arterial occlusion with LIF using rTPA.
    Hayreh SS
    Ophthalmology; 1999 Jul; 106(7):1236-9. PubMed ID: 10406599
    [No Abstract]   [Full Text] [Related]  

  • 18. The tissue-type plasminogen activator story.
    Collen D; Lijnen HR
    Arterioscler Thromb Vasc Biol; 2009 Aug; 29(8):1151-5. PubMed ID: 19605778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Problems over TPA patent for Genentech in Japan.
    Swinbanks D
    Nature; 1988 Jun; 333(6174):587. PubMed ID: 3131683
    [No Abstract]   [Full Text] [Related]  

  • 20. Tissue plasminogen activator therapy for the eye.
    Tripathi RC; Tripathi BJ
    Br J Ophthalmol; 2005 Nov; 89(11):1390-1. PubMed ID: 16234434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.